Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas.

作者: Dimitri Barski , Marietta Wolter , Guido Reifenberger , Markus J. Riemenschneider

DOI: 10.1111/J.1750-3639.2009.00340.X

关键词:

摘要: The gene for the tissue inhibitor of metalloproteinase 3 (TIMP3) on 22q12.3 had been reported to be inactivated by promoter methylation in various types cancers, with controversial findings meningiomas. We performed direct sodium bisulfite sequencing a series 50 meningiomas, including 27 benign meningiomas [World Health Organization (WHO) grade I], 11 atypical (WHO II) and 12 anaplastic III), found hypermethylation TIMP3 67% but only 22% 17% Moreover, scores were significantly inversely correlated mRNA expression levels (P = 0.0123), treatment meningioma cell line Ben-Men-1 demethylating agents induced an increased expression. is located chromosomal band 22q12, allelic loss which occurs early tumorigenesis preferentially targets NF2 tumor suppressor gene. In our panel, all hypermethylation--except single case--exhibited losses 22q12.3. Thus, inactivation seems fairly exclusive 22q12 but--in contrast mutation--appears involved progression as it associated more aggressive, high-grade phenotype.

参考文章(32)
Suneel S. Apte, Bela Anand-Apte, Michael S. Pepper, Bjorn Olsen, Bruce Zetter, Roberta Montesano, Gillian Murphy, Emile Voest, Inhibition of Angiogenesis by Tissue Inhibitor of Metalloproteinase-3 Investigative Ophthalmology & Visual Science. ,vol. 38, pp. 817- 823 ,(1997)
Mitsutoshi Nakamura, Eiwa Ishida, Keiji Shimada, Munehiro Kishi, Hiroyuki Nakase, Toshisuke Sakaki, Noboru Konishi, Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas. Laboratory Investigation. ,vol. 85, pp. 165- 175 ,(2005) , 10.1038/LABINVEST.3700223
Timmo H. Koy, Guido Reifenberger, Markus J. Riemenschneider, Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas. Acta Neuropathologica. ,vol. 107, pp. 277- 282 ,(2004) , 10.1007/S00401-003-0809-8
Marja Hilska, Peter J. Roberts, Yrjö U. Collan, Veli Jukka O. Laine, Jyrki Kössi, Pirkko Hirsimäki, Otto Rahkonen, Matti Laato, Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer International Journal of Cancer. ,vol. 121, pp. 714- 723 ,(2007) , 10.1002/IJC.22747
Yanhui Liu, Jesse Chung-sean Pang, Shumin Dong, Boyong Mao, Wai Sang Poon, Ho-keung Ng, None, Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Human Pathology. ,vol. 36, pp. 416- 425 ,(2005) , 10.1016/J.HUMPATH.2005.02.006
Bela Anand-Apte, Lere Bao, Roy Smith, Bruce Zetter, Kazushi Iwata, Bjorn R. Olsen, Suneel S. Apte, A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth Biochemistry and Cell Biology. ,vol. 74, pp. 853- 862 ,(1996) , 10.1139/O96-090
A C P Riddick, C J Shukla, C J Pennington, R Bass, R K Nuttall, A Hogan, K K Sethia, V Ellis, A T Collins, N J Maitland, R Y Ball, D R Edwards, Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. British Journal of Cancer. ,vol. 92, pp. 2171- 2180 ,(2005) , 10.1038/SJ.BJC.6602630
R. G. Weber, J. Bostrom, M. Wolter, M. Baudis, V. P. Collins, G. Reifenberger, P. Lichter, Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 14719- 14724 ,(1997) , 10.1073/PNAS.94.26.14719
Dylan R Edwards, TIMP-3 and endocrine therapy of breast cancer: an apoptosis connection emerges. The Journal of Pathology. ,vol. 202, pp. 391- 394 ,(2004) , 10.1002/PATH.1548